Oncological prevention program prepared by companies 
& 
OnkoRadar
Cancer is the second cause of death among Poles, and our mortality rate is higher than the EU average. Conduct a comprehensive personal risk assessment and learn about recommendations that will reduce your risk of cancer.
- Wypełniasz ankietę
- Oddajesz krew
- Badamy DNA oraz onkopierwiastki
- Otrzymujesz raport ryzyka i zalecenia
OnkoRadar package
Analysis of pedigree and clinical data
Investigation of the most common high-risk oncological genetic mutations
- BRCA1
- CHEK2
- PALB2
- NBN
Testing the concentration of key oncoelements responsible for a high risk of oncological diseases
- Arsenic (As)
- Selenium (Se)
- Zinc (Zn)
Modern oncological prevention
Medicine knows more and more about the causes of cancer, but this scientific knowledge is not easily accessible and understandable to the average person, and therefore is not widely used in prevention. Moreover, we detect cancer too late, so their treatment is less effective.
Cancer is the second leading cause of death in Poland (after circulatory system diseases), accounting for 25% of deaths*. The results of genetic tests have shown that approximately 3 million people in Poland have a high inherited predisposition to cancer, including approximately 1 million who are mutation carriers.
According to the latest scientific publications, abnormal concentrations of important oncoelements, such as Arsenic, Selenium or Zinc, may be responsible for the increased risk of oncological diseases.
Rich knowledge and many years of clinical experience of Read-Gene S.A. – an internationally renowned cancer prevention center, was collected and presented in the form of a simple, friendly mobile application available to everyone.
Top Quality
OnkoRadar offers the highest quality of medical analyzes and procedures, guaranteed by a team of internationally renowned oncogenetics professors. Many of the research methods used in OnkoRadar are covered by patent protection.
A simple process
It’s very simple. Download the OnkoRadar application, purchase the service and complete the pedigree and clinical data survey in the application. Then go to a nearby collection point to donate blood for testing. Your samples will go to the Diagnostic Laboratory, where it will be checked whether you have DNA mutations that increase the risk of developing cancer and your concentration of key oncoelements. All results will be analyzed and assessed by the Professor’s team and then, within 30 days from the date of blood donation, provided to you in the form of a specialized, digital medical report. If there are medical indications, you will receive an additional professorial teleconsultation with an oncogeneticist who will explain the results and further medical procedure.
1. Pay for the service
2. Complete The Survey
4. Get your report
